A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Voriconazole Impurity 37 - Request Quote

Picture of Voriconazole Impurity 37

Voriconazole Impurity 37

SZ CAT No:SZ-V012047
CAS No
NA
Mol.F.
C16H17N5O
Mol.Wt.
295.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Voriconazole Impurity 37 is chemically (2R,3S)-2-Phenyl-3-(pyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol. Voriconazole Impurity 37 is supplied with detailed characterization data compliant with regulatory guideline. Voriconazole Impurity 37 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Voriconazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Voriconazole Impurity 37

Purchase Voriconazole Impurity 37

Voriconazole Impurity 37 suppliers

Voriconazole Impurity 37 manufacturers

Voriconazole Impurity 37 price

Order Voriconazole Impurity 37

Enquire Voriconazole Impurity 37

Voriconazole Impurity 37 cost

Voriconazole Impurity 37 Supplier

Voriconazole Impurity 37 Distributor

Voriconazole Impurity 37 for Method Validation

Voriconazole Reference Standard

Voriconazole Impurity 37 for ANDA Filing

Voriconazole Impurity 37 for Forced Degradation Studies

Voriconazole Impurity 37 Identification Standards

Voriconazole Impurity 37 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,